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a  b  s  t  r  a  c  t
Noroviruses  (NoVs)  are  an  important  human  pathogen  associated  with  acute  viral  gastroenteritis
worldwide.  NoVs  display  a  signiﬁcant  amount  of  genetic  heterogeneity,  making  it  difﬁcult  to  develop
comprehensive  detection  assays.  In this  study,  primer  sets  and  probes  were  designed  for  a  TaqMan®-
based  real-time  reverse  transcription-polymerase  chain  reaction  (RT-PCR)  for  norovirus  detection
purposes.  The  assay  was  optimized  and  utilized  as  a multiplex  real-time  RT-PCR  assay  for  genogroup
I  (GI)  detection,  and  a singleplex  real-time  RT-PCR  assay  for genogroup  II (GII) detection.  The assays
showed  high  speciﬁcity  for NoV  detection  and  no cross-reactivity  was  observed  between  GI  and  GII.  The
detection  limit  of the  assay  was  as  low  as 10 and  50  RNA  copies  per  reaction  for  GI and  GII,  respec-
tively.  The  optimized  protocol  was  employed  to  assess  the  presence  of  NoV  strains  in clinical  samples
collected  throughout  Thailand  during  December  2005  to November  2006.  The  percentage  of  NoV  infec-
tions  among  children  with  acute  gastroenteritis  (case)  was  23.8%  (119/500)  and  for children  without
acute  gastroenteritis  (control)  it was  6.8%  (30/441).  The  frequency  of  NoV  infections  varied  geographi-
cally,  with  the  highest  frequency  observed  in the  central  region  and  the  lowest  frequency  in the northern
region  (P  > 0.0001).  Of the 149  positive  case  and  control  specimens,  GII was  found  to be the  predominant
genogroup  (98.6%).  Partial  capsid  sequences  were  successfully  obtained  from  67 NoV-positive  specimens
and  a phylogenetic  analysis  was  performed  to  genotype  the viral  strains.  GII.4 was  the  most  common
 2013
genotype  detected.
©
. Introduction
Noroviruses (NoVs) are the leading cause of gastroenteritis
utbreaks worldwide (Atmar and Estes, 2001; Jones et al., 2008)
nd are estimated to cause ∼200,000 deaths annually in children
nder 5 years of age in the developing world (Patel et al., 2008).
oVs are members of the positive-sense, single-stranded RNA virus
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family, Caliciviridae, and are classiﬁed within the genus Norovirus
(NoV). NoVs affect all age groups and outbreaks are characterized
for its occurrence in closed or semi-closed communities such as
schools, hospitals, nursing homes, military bases, cruise ships, and
restaurants (Fankhauser et al., 2002; Lindesmith et al., 2008; White
et al., 2002; Widdowson et al., 2005). The virus is typically trans-
mitted by the fecal–oral route, although infectious particles have
been reported in vomitus and can spread through contaminated
food and water, or environmental surfaces contaminated with
NoVs. NoVs are small (∼38 nm), non-enveloped viruses (Prasad
et al., 1994). The genome (∼7.5 kb) is organized into 3 open reading
Open access under CC BY-NC-ND license.frames (ORFs) (Jiang et al., 1992b). ORF1 encodes a polyprotein that
is subsequently processed into at least six nonstructural proteins.
ORF2 encodes the capsid protein (VP1), and ORF3 encodes the basic
minor structural protein (VP2). Similar to other positive-sense
 license.
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Fig. 1. Illustration of primers and probes targeted on the ORF1–ORF2 junction of NoV GI and GII. (A) Alignment of nucleotide sequences used to design primers and
probes  for real-time RT-PCR assays. NoV genotypes and accession numbers are shown to the left of the sequences. The ﬁrst nucleotide sequence of each alignment was
designated as a reference strain (accession number M87661 for the GI alignment and AF145896 for the GII alignment). Nucleotide positions shown above the alignments refer
to  the reference strains. Dots indicate nucleotides that are identical to the reference strain. The consensus sequence is shown at the bottom of each alignment. The sequences of
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ingle-stranded RNA viruses, NoVs have a rapid rate of evolution
Bok et al., 2009; Boon et al., 2011) and are characterized for having
igh genetic diversity. They are classiﬁed into 5 genogroups (GI
o GV) (Zheng et al., 2006) based on nucleotide sequence of the
apsid gene. GI and GII are the strains most frequently associated
ith human disease. GIV strains have also been associated with
ausing disease in humans, although to a much lower extent than
I and GII. GIII and GV are found in bovine and mice, respectively
Chakravarty et al., 2005; Fankhauser et al., 2002; Hutson et al.,
004; Radford et al., 2004).
The ﬁrst NoV strain associated with gastroenteritis (Nor-
alk virus) was discovered in 1972 by use of immunoelectron
icroscopy (Kapikian et al., 1972). Currently, the standard assay for
oV detection is reverse transcription-polymerase chain reaction
RT-PCR) in which various combinations of primer sets are used
n order to broaden the sensitivity of the assay. Several primer
ets have been described in the literature that target conserved
egions within ORF1 (Ando et al., 1995; Ando et al., 1997; Jiang
t al., 1992a; Moe  et al., 1994; Vinje et al., 2004), although in the
ast decade, several publications have reported improved primer
ets that target the ORF1–ORF2 junction (Hymas et al., 2007;
othikumar et al., 2005; Kageyama et al., 2003; Trujillo et al., 2006;
olf et al., 2007). Due to the lack of conserved regions among
oVs and the ability of the virus to recombine (Chakravarty et al.,
005; Hutson et al., 2004), it is difﬁcult to design primers that
ave a broad reactivity across the many described human NoV
trains. Furthermore, a multi-center study that analyzed results
rom 9 different laboratories in the United States and Canada that
ested a panel of norovirus positive stool samples reported variable
uccess rates of NoV detection and genotyping despite the use of
wo standardized protocols (Mattison et al., 2009), highlighting
he importance of assay optimization. Some of the variables that
ffected the success rate of NoV detection and genotyping include
he method utilized for RNA extraction and the reagents and the
onditions of the RT-PCR assay. Additionally, Van Stelten et al.
2011) have reported that assay optimization and primer and
robe sequence modiﬁcations to address new strains submitted to
enBank can lead to increased detection sensitivity.
This report describes the optimization of primers and TaqMan®
robes to utilize in one-step real-time RT-PCR assays for NoV GI
nd GII detection using an ABI 7900 platform. The optimized assays
ere employed to analyze 941 stool specimens collected from a
ase–control study performed in Thailand. Conventional PCR was
erformed on a subset of positive samples to amplify the capsid
ene. Phylogenetic analysis of 5’ end of the capsid gene conﬁrmed
he speciﬁcity of the assay to distinguish between NoV GI and GII,
ndicating that the assay may  be a useful diagnostic tool for main-
aining surveillance of circulating strains and for detecting novel
trains that may  emerge.
. Materials and methods
.1. Specimen collectionA case–control study was conducted throughout 5 regions of
hailand during December 2005 to November 2006. The Ethical
eview Committee for Research in Human Subjects, Ministry of
ublic Health, Thailand approved the study protocol. Informed
rimers and probes are indicated below the alignments with arrows to indicate polarity w
robes  described by Kageyama et al. (2003) are shown in order to compare with those de
sed  in this study. Degenerate nucleotides within the primer or probe sequences are un
reviously published primer and probe sets targeted on the ORF1–ORF2 junction. NoV gen
umber: M87661 was  designated as a reference strain to refer to the nucleotide positio
ucleotide sequences according to the reference strains. The consensus sequences are th
hown  in the left. The primers and probes are indicated by the lines with closed arrowhead
he  nucleotide positions and the plus (+) and minus (−) symbols indicate polarity of priml Methods 194 (2013) 317– 325 319
consent was obtained from parents or guardians of enrolled
patients. Clinical and background data was recorded for enrolled
patients using a standard study questionnaire. Case patients were
deﬁned as those who  had three or more loose stools per 24-h
period with at least one additional symptom (nausea, vomiting,
abdominal pain, fatigue/lethargy, or fever). Control patients were
deﬁned as children within the same age group who had visited or
been admitted to the same hospital and had not experienced diar-
rhea during the previous 2 weeks. Case and control patients were
children aged between 3 months and 5 years old. The 5 collection
sites were Mae  Hong Son Province (north, N), Ubon Ratchathani
Province (northeast, NE), Trang Province (south, S), Samut
Songkhram Province (central, C), and Bangkok (Capital city, CH).
Approximately 68–90 stool specimens were collected monthly.
The stool specimens were stored at −70 ◦C until RNA extraction.
2.2. Viral RNA preparation
Total nucleic acid was extracted using the NucliSens mini MAG
RNA extraction system (BioMerieux Inc., Durham, NC). Brieﬂy, a
10% (w/v) stool suspension was  clariﬁed by centrifugation at 2600
× g for 10 min. Then, 300 l of the clariﬁed stool suspension was
treated with 1.2 ml  lysis buffer followed by multiple puriﬁcation
steps according to the manufacturer’s instructions (BioMerieux
Inc.). The RNA was eluted in 70 l of elution buffer and stored at
−70 ◦C until further use.
2.3. Primer and probe design
Multiple-sequence alignments (Fig. 1) of representative GI and
GII strains were performed using the ClustalW feature provided by
BioEdit software (Hall, 1999). The ORF1–ORF2 junction was cho-
sen as the target region for primer and probe design. The primers
and TaqMan probes were designed and optimized for melting tem-
peratures (Tm) according to guidelines of Primer Express software
version 2.0 (Applied Biosystems, Foster City, CA). Primer and probe
sequences for both assays are shown in Table 1.
2.4. Positive controls and standards for real-time RT-PCR
DNA plasmids containing cloned GI and GII capsid gene frag-
ments (pJPGI and pJPGII) were gifts from Dr. Kageyama (Kageyama
et al., 2003). The DNA plasmids were used as DNA  positive con-
trols for optimizing the real-time RT-PCR assays. Synthetic NoV
RNAs were synthesized using RNA Maxx High Yield Transcription
kit (Stratagene LaJolla, CA) with recombinant plasmids harboring
Thai isolates corresponding to GI.3 (Genbank: HQ693091) and GII.4
(GenBank: HQ693090). The synthetic RNAs were quantiﬁed using a
NanoDrop Spectrophotometer (Labtech, Dublin, Ireland) and used
to establish standard curves and used as RNA positive controls for
real-time RT-PCR assays.
2.5. Development and optimization of one-step real-time RT-PCR
assays
Two  real-time RT-PCR assays speciﬁc for the detection of NoV GI
and GII genogroups were developed. Control plasmids (pJPGI and
ith either closed arrowheads (primers) or open arrowheads (probes). Primers and
signed in this study. Rectangles indicate regions used to design primers and probes
derlined. (B) Location of primers and probes reported in this study compared to
otypes and accession numbers are shown to the left of the sequences. The accession
n of the GI and AF145896 was for the GII. Nucleotide positions shown above the
e same as Fig. 1A. The author and year of the published primer and probe sets are
s (primers) and open arrowheads (probes). Under the lines, the numbers represent
er and probe strains.
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Table  1
List of primers and probes used in this study for NoV detection by real-time RT-PCR and for ampliﬁcation of NoV capsid gene by conventional PCR.
Primer/probe Sequence (5′ to 3′ , targeted strand) Nt position (Acc. no.) Reference
GI-F1 a,b ATGTTCCGYTGGATGCGIT, sense 5285–5303 (M87661) Complementary to Mon  434 (Richards et al., 2004)
GI-F2 a,b TTGGATGCGITTYCATGA, sense 5291–5307 (L07418) Modiﬁed COG1F (Kageyama et al., 2003)
GI-R1 c GGTCAGAAGCATTAACCTCCG, antisense 5425–5445 (M87661) This study
GI-R2 c GGTCAGCTGTATTAACCTCCG, antisense 5425–5445 (M87661) This study
GI-R3 c AGCTGRCCGGCACCACT, antisense 717–733 (JN8992463) This study
GI-R4 c CACTRGTGCCATCCATGTTT, antisense 680–720 (JN8992463) This study
GI-TP d (VIC) GCGTCCTTAGACGCCATCTTCATTTAC, antisense 5354–5380 (M87661) COG1R (Kageyama et al., 2003)
GII-F a,b BCIATGTTYAGRTGGATGAG, sense 5009–5018 (AF145896) Modiﬁed COG2F (Kageyama et al., 2003)
GII-R c CGACGCCATCTTCATTCAC, antisense 5081–5099 (AF145896) Modiﬁed COG2R (Kageyama et al., 2003)
GII-TP d (FAM) AGATTGCGATCGCCCTCCCA, antisense 5048–5068 (AF145896) Complementary to RING2-TP (Kageyama et al., 2003)
GI-R6947 e ATIATRGCTTGRGCCATTAT, antisense 6928–6947 (M87661) This study
GII-R6709 e CAAWYAAAGCTCCWGCCATT, antisense 6690–6709 (AF145896) This study
a Forward primer for real-time RT-PCR.
b Forward primer for conventional PCR and sequence analysis.
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Gc Reverse primer for real-time RT-PCR.
d Probe for real-time RT-PCR.
e Reverse primer for conventional PCR and sequence analysis.
JPGII) were used as positive controls for developing and optimi-
ing the assays. The reactions were optimized for Mn(OAc)2, primer
nd probe concentrations. The TaqMan® EZ RT-PCR Core Reagent
it (Applied Biosystems) was used to prepare reaction mixes con-
aining the following: 3.0 mM Mn(OAc)2, 300 M of each dNTP,
.5 M of forward primer mix  and 2.0 M of reverse primer mix,
00 nM of probe, 1.5 U of rTth DNA polymerase, 0.15 U of Uracyl N-
lycosylase for the GI assay and 2.0 mM Mn(OAc)2, 300 M of each
NTP, 1.5 M of each forward and reverse primer, 60 nM of probe,
.5 U of rTth DNA polymerase, 0.15 U of Uracyl N-glycosylase for
he GII assay. Three microliters of total nucleic acid extracted from
tool specimen was utilized as template in each one step real-time
T-PCR reaction (20 l ﬁnal volume). Cycling conditions for each
ssay consisted of incubating the sample at 50 ◦C for 2 min, 60 ◦C
or 30 min, 95 ◦C for 10 min, followed by 40 cycles of PCR, with each
ycle consisting of 95 ◦C for 15 s and then 60 ◦C for 1 min. All reac-
ions were carried out in an ABI PRISM 7900 Sequence Detector
ystem and the results were analyzed with Sequence Detection
oftware version 2.1 (Applied Biosystems). Synthetic GI and GII
NA, corresponding to GI.3 and GII.4 genotypes, were included as an
NA control in every run. A standard curve was established for each
ssay with known concentrations of synthetic RNA tested in tripli-
ate. The concentration of NoV positive specimens was calculated
sing the relative standard curve method according to the chem-
stry guide book (Applied Biosystems). The limit of detection (LOD)
f the assay was deﬁned as the lowest concentration of synthetic
oV RNA detected in at least 28 out of 30 replicates.
.6. Ampliﬁcation of the capsid gene
Primers were designed to amplify a region that consisted of the
RF1–ORF2 junction through the end of the capsid gene (Table 1).
he capsid genes were ampliﬁed from positive specimens using
enAmp RNA Gold PCR core kit (Applied Biosystems) for reverse
ranscription and with GeneAmp PCR core kit (Applied Biosys-
ems) for PCR. The reverse transcription reaction was  prepared
ontaining the following: 0.4 mM dNTPs mixture, 3.0 mM MgCl2,
00 nM of mixed oligo-dT, hexamer, and reverse primers, and
ultiscript enzyme 0.25 U. The RT reaction was performed in a
eneAmp PCR system 9700 instrument (Applied Biosystems) fol-
owing the instructions of the manufacturer. The PCR mixture was
repared containing the following: 1× buffer II, 0.2 mM dNTPs mix-
ure, 3.0 mM MgCl2, AmpliTaq Gold 0.5 U and 800 nM of forward or
everse primers for each genogroup. The PCR proﬁle was  94 ◦C for
 min  followed by 40 cycles of 94 ◦C for 1 min, 46 ◦C for 1 min, 72 ◦C
or 1 min  45 s, followed by a ﬁnal single cycle at 72 ◦C for 7 min  in a
eneAmp PCR system 9700 instrument.2.7. Sequence analysis of the 5’ end of the capsid gene
PCR ampliﬁed capsid genes were analyzed by gel electrophore-
sis and visualized with ethidium bromide. PCR products with the
band of expected size were excised and puriﬁed using QIA-quick
gel extraction kit (Qiagen Inc., Valencia, CA). PCR products in which
a distinct band was  observed were submitted for direct sequenc-
ing. The PCR products with faint bands were cloned into a PCR 4
TOPO-cloning vector (Invitrogen, Carlsbad, CA) following the proto-
col of the manufacturer. Clones were grown overnight and plasmids
were puriﬁed using the QIAprep spin miniprep kit (Qiagen Inc.).
Puriﬁed plasmids were screened for the insertion using the real-
time RT-PCR assay described above. Then, clones that contained
the insertion were submitted for sequencing. Sequencing of 5’ end
of all PCR products were performed with BigDye terminator cycle
sequencing kit V3.1 on a ABI310 genetic analyzer (Applied Biosys-
tems). The quality of the sequencing reads was  determined by using
the DNA Sequencher program version 4.0.
2.8. NoV genotyping and phylogenetic analysis and accession
number
Genotypes were assigned to sample sequences using two  meth-
ods. First, sequences corresponding to a 239-nt region of the 5’ end
of the capsid gene were used to perform a phylogenetic analysis.
Forty one reference sequences from two genotyping classiﬁcation
systems (Okada et al., 2005; Zheng et al., 2006) were downloaded
from GenBank and were used to align with sample sequences
from this study. The phylogenetic relationship between strains
was reconstructed using the Maximum Likelihood method based
on the General Time Reversible model and a bootstrap analysis
(1000 replicates) was used to assess the statistical conﬁdence of
the branches with MEGA 5.1 (Tamura et al., 2011). Second, sample
sequences were submitted to an online genotyping tool (Kroneman
et al., 2011) to conﬁrm genotype assignments.
The nucleotide sequences have been deposited into NCBI-
GenBank (www.ncbi.nlm.nih. gov/genbank). The accession num-
bers of NoV strains in this study were GenBank: KC911646 to
KC911711.
2.9. Statistical analysisThe differences among clinical specimen data sets were
analyzed using Pearson’s chi-squared test. The probability (p)
value was calculated using Simple Interactive Statistic Analysis
(www.quantitativeskills.com/sisa/statistics). The clinical specimen
P. Neesanant et al. / Journal of Virological Methods 194 (2013) 317– 325 321
Table  2
Proportion of real-time RT-PCR NoV-positive samples from 5 sites in Thailand during December 2005 to November 2006.
Region Number of cases Positive samples (% positive) Number of controls Positive samples (% positive) % positive of total specimen
GI GII Total GI GII Total
North, N 106 1 (0.9) 14 (13.2) 15 (14.2) 39 0 (0.0) 1 (2.6) 1 (2.6) 11.0
Central,  C 70 0 (0.0) 25 (35.7) 25 (35.7) 64 0 (0.0) 11 (17.2) 11 (17.2) 26.9
Capital  city, CH 115 0 (0.0) 32 (27.8) 32 (27.8) 120 1 (0.8) 4 (3.3) 5 (4.2) 15.7
North  East, NE 101 1 (1.0) 27 (26.7) 28 (27.7) 114 0 (0.0) 6 (5.3) 6 (5.3) 15.8
South,  S 108 1 (0.9) 18 (16.7) 19 (17.6) 104 1 (1.0) 6 (5.8) 7 (6.7) 12.3
Total  500 3 (0.6) 116 (23.2) 119 (23.8) 441 2 (0.5) 28 (6.4) 30 (6.8) 15.8
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Eig. 2. Monthly distribution of NoV positive-samples detected by real-time RT-PCR.
emperatures for Thailand are plotted for each corresponding month.
ata sets included the proportion of NoV infections in case and con-
rol samples, and the frequency of NoV infections by region and
eason.
. Results
.1. Development and optimization of real-time RT-PCR assays
or NoV detection
The real-time RT-PCR was designed to target the ORF1–ORF2
unction of the NoV genome. Primers and probes from previously
eports (Fankhauser et al., 2002; Kageyama et al., 2003) were mod-
ﬁed to optimize the melting temperatures (Tm) for TaqMan®
robe-based real-time RT-PCR assays. Primers and probes were
odiﬁed so that the predicted Tm of probes were at least 7 ◦C
igher than the Tm of the primer sets and that the Tm within primer
ets did not vary more than 2–3 ◦C. Employing primers with degen-
rate nucleotides, a multiplex real-time RT-PCR was designed for
I detection and a singleplex real-time RT-PCR for GII detection
Table 1). To improve the speciﬁcity of the GI assay, the GI probe
as designed to target a conserved 26-nt region at the 5’ end ofhe capsid gene and multiple forward and reverse primers were
esigned to react with different GI clusters (Fig. 1). For the GII assay,
 previously reported forward primer was modiﬁed to reduce the
umber of degenerate bases in order to avoid potential non-speciﬁc
able 3
stimated viral loads of real-time RT-PCR NoV-positive samples.
Viral load (copy/gram of stool) GI positive (%)
Cases (N = 3) Contr
<105 – – 
105–106 – – 
106–107 1 (33.3%) 1 (50
107–108 2 (66.7%) – 
>108 – 1 (50mples were collected in Thailand from December 2005 to November 2006. Average
priming. The expected amplicon sizes for the GI and GII RT-PCR
were 150 and 90 base pairs, respectively.
One-step and two-step real-time PCR assays were individually
optimized and tested side-by-side in order to compare the sensitiv-
ity of each assay. The NoV strains used as positive controls had been
previously genotyped based on the capsid sequence, and included
GI.1, 2, 3, 4, 6 and GII.2, 3, 4, 6, 10. Both assays successfully dis-
tinguished between all NoV GI and GII positive controls tested. No
sensitivity differences were observed, as measured by the thresh-
old cycle (Ct) value, between a one-step (TaqMan® EZ RT-PCR) and
two-step (TaqMan PCR Gold) real-time PCR with the positive con-
trols (data not shown). To minimize reaction duration and reduce
use of consumables, the one-step real-time RT-PCR was  selected
for further study.
The speciﬁcity of the optimized assays were examined by test-
ing against a panel of 20 known positive and 30 known negative
controls. The nucleic acid extracts were prepared from the known
control specimens by the same procedure described in the meth-
ods above. The panel of negative controls included several common
enteric pathogens such as Campylobacter spp., Salmonella spp.,
Shigella spp., Vibrio spp., Diarrheagennic E. coli, and enteric viruses
including sapoviruses, rotaviruses, and astroviruses. Assay results
of the panels were as expected where negative controls tested
were negative and NoV positive controls were successfully detected
(data not shown). For each genogroup-speciﬁc assay, a standard
GII positive (%)
ols (N = 2) Cases (N = 116) Controls (N = 28)
8 (6.9%) 4 (14.3%)
5 (4.3%) 2 (7.1%)
%) 20 (17.2%) 5 (17.9%)
53 (45.7%) 6 (21.4%)
%) 30 (25.9%) 11 (39.3%)
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Fig. 3. Phylogenetic tree based on the partial capsid sequence of NoVs detected in Thailand during December 2005 to November 2006 and reference strains. The
Bo/NLV/GIII/Aba-25 virus strain was used as the outgroup. The phylogeny was inferred by using the maximum likelihood method with the general time reversible
substitution model (Nei and Kumer, 2000). Branch nodes are labeled with bootstrap values in cases where the bootstrap value was >75% (1000 replicates). NoV genotypes
are  shown on the right of the phylogenetic tree and correspond to the classiﬁcation system reported by Kroneman et al. (2011). The reference sequences used by Okada et al.
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urve was established by performing the assay in triplicate with
nown concentrations of an RNA control synthesized in vitro that
orresponded to GI.3 and GII.4. The correlation coefﬁcient (R2) and
lope (m) of the GI and GII standard curves were 0.99 and −3.44, and
.98 and −3.54, respectively. The y-intercept (b), which represents
he Ct value at which a single copy of the target molecule can be
etected, was 40.5 and 35.7 for the GI and GII assays, respectively.
he limit of detection (LOD) was established by testing known con-
entrations of synthetic RNA corresponding to GI.3 and GII.4. The
OD was determined by observing the lowest concentration of syn-
hetic RNA that was positive in 28/30 replicates in at least 3 separate
uns. The LOD observed for the GI and GII assays were 10 and 50
NA copies per reaction, respectively.
.2. Identiﬁcation of NoVs in clinical specimens
The real-time RT-PCR assays were tested as a diagnostic tool
y evaluating 941 clinical case–control specimens. Of the 941
pecimens, 500 were case specimens (children with acute gastroen-
eritis) and 441 were control specimens. All specimens were tested
ith both the GI and GII assays. From the case specimens, 119
23.8%) were positive for NoV, of which 116 were GII (97.5%) and 3
ere GI (2.5%). Among the control specimens, 30 were positive for
oV (6.8%), of which 28 were GII (93.3%), and 2 were GI (6.7%). The
ifference in NoV infection rates between case and control samples
as signiﬁcant (p < 0.0001). The geographical distribution of NoV
nfections is shown in Table 2 and the frequency of NoV infections
aried signiﬁcantly among the regions (p < 0.002). Among all NoV-
ositive specimens, the highest detection rate was  observed in the
entral region of Thailand (26.9%), whereas the lowest detection
ate was observed in the northern region (11%). In order to assess
hether NoV was seasonal, two periods were deﬁned for this study
ased on temperature: warm (>28.5 ◦C; March to July 2006, which
ncludes summer and the beginning of the rainy season) and cool
<28.5 ◦C; November 2005 to February 2006 and August to October
006, which includes winter and most of the rainy season). The
roportion of NoV-positive samples was higher during the cooler
onths (Fig. 2), and the difference when compared to the warmer
onths was signiﬁcant (p < 0.0001 in cases and p < 0.02 in control).
I stool viral loads ranged from >106–108 copies per gram of stool
N = 5), and GII viral loads ranged from >105–108 copies per gram
f stool (N = 144) (Table 3).
.3. Evolutionary analysis of NoV strains circulating in Thailand
To investigate the genetic variability of NoVs in Thailand, con-
entional PCR was performed on all of the positive specimens
N = 149) in order to amplify the capsid gene. Sequence data was
uccessfully obtained for 67 out of 149 positive samples (43 by
irect PCR sequencing and 24 by cloning and then sequencing).
he phylogenetic analysis (Fig. 3) and RIVM online genotyp-
ng tool identiﬁed the 2 GI strains as GI.3 and GI.6. Of the 65
equences that were GII positive, GII.4 was the predominant geno-
ype detected (67.2%), followed by GII.3 (19.4%). Other genotypes
etected included GII.17 (3.0%), GII.21 (3.0%), GII.2 (1.5%), GII.6
1.5%), and GII.12 (1.5%).. Discussion
This report describes two one-step real-time RT-PCR assays
hat employ degenerate primers and have been optimized for the
2005) were included in the phylogenetic tree in order to compare genotype from this 
equences from Okada et al. (2005). NoV GI and GII reference sequences are indicated with
oV  reference strains differ between the two  classiﬁcation schemes, both genotype assign
nd  rivm refers to the online genotyping tool reported by Kroneman et al. (2011). NoV stl Methods 194 (2013) 317– 325 323
detection of GI and GII NoVs. Initial testing of these assays were
performed with recombinant plasmids containing fragments of GI
and GII capsid genes and standard curves were established with
synthetic RNA produced in vitro. Synthetic RNA corresponding to
GI.3 and GII.4 was included in each run as RNA positive controls.
Analysis of the LOD suggests that the GI assay has a higher sensi-
tivity (10 RNA copies per reaction) when compared to the GII assay
(50 RNA copies per reaction). The sensitivity of the GI assay in this
study, as measured by LOD, was higher when compared to other
reports that also targeted the ORF1-2 junction and used synthetic
RNA (Trujillo et al., 2006) or RNA extracted from a positive stool
sample (Hymas et al., 2007) to calculate the LOD, and comparable
to other reports in which DNA plasmids were used to calculate the
LOD (Jothikumar et al., 2005; Kageyama et al., 2003; Kamata et al.,
2005; Wolf et al., 2007). The GI assay generates a PCR amplicon that
includes regions targeted by other reported probes so that multiple
probes could potentially be used in a single reaction if needed. The
LOD (50 copy/reaction) of the GII assay was comparable (Hymas
et al., 2007) or slightly higher when compared to other assays.
Repeatability (detection in 28/30 reactions using quantiﬁed
synthetic RNA) and reproducibility (three separate runs on three
different experimental dates) was  taken into account to ensure the
accuracy of the LOD reported in this study. The speciﬁcity of the
assays was conﬁrmed by testing against a panel of known positive
and negative samples. The assays successfully detected all NoV pos-
itive controls tested and there was no cross-reactivity with a panel
of enteric pathogens that included enteric viruses.
Once optimized, the assays were employed to analyze 941 clin-
ical specimens from a case–control study carried out in various
regions of Thailand. NoVs were detected in 116 specimens from
case patients (23.8%) and 30 specimens from control patients (6.8%),
representing similar detection rates when compared to previous
reports (Monica et al., 2007; Ozawa et al., 2007). The difference
in NoV infection rates between case and control samples suggests
that NoVs are an important cause of acute gastroenteritis in Thai
children (p < 0.0001). These data suggests, along with several other
studies (Patel et al., 2008; Hoe Tran et al., 2013), that NoV plays an
important role in causing acute gastroenteritis in children <5 years
of age. In acute diarrhea cases in this study, NoVs were the fourth
most commonly detected enteric pathogen following Campylobac-
ter spp., Diarrheagennic E. coli, and rotaviruses. The frequency of
NoV infections varied geographically, with the highest prevalence
observed in the central region and the lowest prevalence observed
in the northern region (p < 0.0001). The percentage of NoV infec-
tions in the northern region (14.2%) is consistent with other studies
from northern Thailand that reported ranges from 8.1 to 14.1%
(Guntapong et al., 2004; Hansman et al., 2004; Khamrin et al., 2007).
A higher proportion of NoV infections were observed in the rainy
season during the cooler months (August to October), consistent
with previously reported data from Lopburi province in the same
year as this study (Kittigul et al., 2009, 2010).
Two  different NoV classiﬁcation systems, that differ in the refer-
ence strains used to assign capsid genotypes, have been proposed.
Several NoV epidemiology studies from Asia, and particularly
Thailand (Guntapong et al., 2004; Hansman et al., 2004; Ho et al.,
2007; Khamrin et al., 2007; Kittigul et al., 2009; Nguyen et al.,
2007; Okada et al., 2005; Phan et al., 2007) have published phloge-
netic data using the classiﬁcation system proposed by Katayama
et al. (2002). In this study capsid genes were assigned geno-
types according to reference strains used by an online genotyping
tool (Kroneman et al., 2011), which is based on the classiﬁcation
study with previously reported NoV strains that were genotyped using reference
 square and triangle symbols, respectively. In cases where the assigned genotype of
ments are indicated: Okada refers to the Okada et al. (2005) classiﬁcation scheme,
rains reported in this study are labeled in bold.
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ystem proposed by Zheng et al. (2006). Although, in order to facil-
tate comparison with strains previously reported as circulating in
sia, reference strains used by Okada et al. (2005), which is based
n the classiﬁcation system proposed by Katayama et al. (2002),
ere also included in the phylogenetic analysis (Fig. 3).
Among the sequenced GI strains, one was identiﬁed as a GI.3
nd the other as a GI.6. Several GII strains were detected, which
ncluded: GII.2, GII.3, GII.4, GII.6, GII.12, GII.17 and GII.21. Simi-
ar to what has been reported worldwide (Gallimore, 2007; Ho
t al., 2007; Kittigul et al., 2009; Nguyen et al., 2007; Phan et al.,
007), GII.4 was the most commonly detected genotype (Fig. 3).
f interest, GII.3 was the second most common genotype detected,
upporting previously reported ﬁndings that GII.3 plays an impor-
ant role in causing disease in young children (Bull et al., 2006;
ahar and Kirkwood, 2011; Okada et al., 2005). Other genotypes
etected in this study such as GII.2, GII.6, GII.12 and GII.21 (GII.16
hen using Okada et al. (2005) reference strains) have been docu-
ented elsewhere in Thailand (Guntapong et al., 2004; Hansman
t al., 2004; Khamrin et al., 2007; Kittigul et al., 2009; Malasao et al.,
008). Moreover, detection of GII.2, GII.3, GII.4, GII.6, and GII.17
trains (GII.11 when using Okada et al. (2005) reference strains) in
his study is consistent with strains previously described as circu-
ating in Thailand during the same time period (Kittigul et al., 2009,
010).
In conclusion, two one-step real-time RT-PCR assays were
eveloped that accurately and speciﬁcally detect NoVs from stool
pecimens. Epochal evolution has been proposed as an important
eterminant for the emergence of novel epidemic strains (Siebenga
t al., 2007), highlighting the need for comprehensive surveillance
ools in order to identify emerging NoV strains. Determining the
opulation of circulating strains and understanding the evolution
f NoV will also help determine vaccine components as new vac-
ine candidates are tested (Atmar et al., 2011; Bok et al., 2011). The
ssays described here are rapid, convenient and have broad reac-
ivity against a wide spectrum of NoV genotypes, and should prove
o be a useful tool for surveillance and epidemiology.
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